| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Amplia Therapeutics Limited (AU: ATX)
ATX Technical Analysis
5
| As on 8th Aug 2025 ATX SHARE Price closed @ 0.20 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.09 & Strong Buy for SHORT-TERM with Stoploss of 0.07 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ATXSHARE Price
| Open | 0.19 | Change | Price | % |
| High | 0.20 | 1 Day | 0.02 | 11.11 |
| Low | 0.19 | 1 Week | -0.04 | -16.67 |
| Close | 0.20 | 1 Month | -0.02 | -9.09 |
| Volume | 5012728 | 1 Year | 0.12 | 150.00 |
| 52 Week High 0.36 | 52 Week Low 0.05 | ||||
AU Australia Most Active Stocks
| PLS | 1.93 | 9.04% |
| WC8 | 0.18 | 5.88% |
| SYA | 0.03 | 50.00% |
| PRX | 0.00 | % |
| LTR | 0.84 | 0.00% |
| TMG | 0.10 | 11.11% |
| AMP | 1.88 | 7.43% |
| RML | 0.06 | % |
| NAE | 0.00 | % |
| VR1 | 0.04 | 0.00% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
| ATX Daily Charts |
ATX Intraday Charts |
Whats New @ Bazaartrend |
ATX Free Analysis |
|
|
ATX Important Levels Intraday
| RESISTANCE | 0.22 |
| RESISTANCE | 0.21 |
| RESISTANCE | 0.21 |
| RESISTANCE | 0.21 |
| SUPPORT | 0.19 |
| SUPPORT | 0.19 |
| SUPPORT | 0.19 |
| SUPPORT | 0.18 |
ATX Forecast August 2025
| 4th UP Forecast | 0.26 |
| 3rd UP Forecast | 0.24 |
| 2nd UP Forecast | 0.23 |
| 1st UP Forecast | 0.22 |
| 1st DOWN Forecast | 0.18 |
| 2nd DOWN Forecast | 0.17 |
| 3rd DOWN Forecast | 0.16 |
| 4th DOWN Forecast | 0.14 |
ATX Weekly Forecast
| 4th UP Forecast | 0.22 |
| 3rd UP Forecast | 0.21 |
| 2nd UP Forecast | 0.21 |
| 1st UP Forecast | 0.21 |
| 1st DOWN Forecast | 0.19 |
| 2nd DOWN Forecast | 0.19 |
| 3rd DOWN Forecast | 0.19 |
| 4th DOWN Forecast | 0.18 |
ATX Forecast2025
| 4th UP Forecast | 0.91 |
| 3rd UP Forecast | 0.68 |
| 2nd UP Forecast | 0.54 |
| 1st UP Forecast | 0.4 |
| 1st DOWN Forecast | -0 |
| 2nd DOWN Forecast | -0.14 |
| 3rd DOWN Forecast | -0.28 |
| 4th DOWN Forecast | -0.51 |
Amplia Therapeutics Limited ( AU Australia Symbol : ATX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ATX Business Profile
Amplia Therapeutics Limited, a pharmaceutical company, engages in the development of focal adhesion kinase (FAK) inhibitors in Australia. The company is developing inhibiting drug candidates, including AMP886 and AMP945 for oncology and chronic fibrosis indications. It has a collaboration agreement with the Garvan Institute of Media Research in Sydney. The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia. Address: 90 Collins Street, Melbourne, VIC, Australia, 3000
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service